On the public citation graph
Landscape of FGF/FGFR Alterations in 12,372 Chinese Cancer Patients
0 signed · 32 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/med.21288openalex-snapshot
FGF Receptors: Cancer Biology and Therapeutics
inferredcites →https://doi.org/10.1016/j.cell.2010.06.011openalex-snapshot
Cell Signaling by Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1016/j.cell.2018.03.035openalex-snapshot
Oncogenic Signaling Pathways in The Cancer Genome Atlas
inferredcites →https://doi.org/10.1016/j.molmed.2011.01.012openalex-snapshot
Targeting mutant fibroblast growth factor receptors in cancer
inferredcites →https://doi.org/10.1016/s1470-2045(20)30109-1openalex-snapshot
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
inferredcites →https://doi.org/10.1038/s41571-018-0115-yopenalex-snapshot
Fibroblast growth factor receptors as treatment targets in clinical oncology
inferredcites →https://doi.org/10.1038/sj.bjc.6606016openalex-snapshot
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
inferredcites →https://doi.org/10.1056/nejmoa1817323openalex-snapshot
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
inferredcites →https://doi.org/10.1093/annonc/mdt419openalex-snapshot
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0890openalex-snapshot
Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-2329openalex-snapshot
Targeting FGFR Signaling in Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-3212openalex-snapshot
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
inferredcites →https://doi.org/10.1186/s13046-017-0591-4openalex-snapshot
High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
inferredcites →https://doi.org/10.1200/po.18.00100openalex-snapshot
Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma HarboringFGFAmplifications
inferredcites →https://doi.org/10.7150/jca.40531openalex-snapshot
FGF/FGFR signaling pathway involved resistance in various cancer types
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4810688openalex-extracted
A Comprehensive Analysis of FGF/FGFRSignaling Alteration in NSCLC:Implications in Prognosis and Microenvironment
inferred← citeshttps://doi.org/10.1002/cam4.6112openalex-snapshot
Epidemiology, treatments, and related biomarkers of locally advanced or metastatic urothelial carcinoma in Chinese population: A scoping review
inferred← citeshttps://doi.org/10.1002/cam4.71235openalex-snapshot
Prognosis and Failure Patterns of 11q13 Amplified Local Advanced Squamous Cell Carcinoma of the Head and Neck
inferred← citeshttps://doi.org/10.1007/s00270-023-03502-1openalex-snapshot
Infigratinib, a Selective Fibroblast Growth Factor Receptor Inhibitor, Suppresses Stent-Induced Tissue Hyperplasia in a Rat Esophageal Model
inferred← citeshttps://doi.org/10.1007/s00428-024-03884-8openalex-snapshot
FGFR3 amplification is predictive of poor prognosis in esophageal squamous cell carcinoma patients
inferred← citeshttps://doi.org/10.1016/j.esmoop.2022.100647openalex-snapshot
Targeting the FGF/FGFR axis and its co-alteration allies
inferred← citeshttps://doi.org/10.1016/j.trecan.2026.01.010openalex-snapshot
FGFR rearrangements: oncogenic drivers and therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.yexcr.2026.115141openalex-snapshot
Neddylation cooperates with multiple phosphorylation to enhance FGFR1 stability and drive breast cancer progression
inferred← citeshttps://doi.org/10.1111/1759-7714.70016openalex-snapshot
A Comprehensive Analysis of FGF / FGFR Signaling Alteration in NSCLC : Implications in Prognosis and Microenvironment
inferred← citeshttps://doi.org/10.1111/cas.15486openalex-snapshot
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors
inferred← citeshttps://doi.org/10.1186/s12885-024-12584-0openalex-snapshot
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
inferred← citeshttps://doi.org/10.3233/blc-201517openalex-snapshot
Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers18010089openalex-snapshot
FGFR Aberrations in Solid Tumors: Mechanistic Insights and Clinical Translation of Targeted Therapies
inferred← citeshttps://doi.org/10.3390/diagnostics15161998openalex-snapshot
ARID1A-Deficient and 11q13-Amplified Metastatic Pancreatic Cancer Initially Presenting as Retroperitoneal Fibrosis in a Patient with Familial CHEK2 Variant
inferred← citeshttps://doi.org/10.3390/neuroglia6040039openalex-snapshot
An FGFR1-Altered Intramedullary Thoracic Tumor with Unusual Clinicopathological Features: A Case Report and Literature Review
inferred← citeshttps://doi.org/10.3390/v14020384openalex-snapshot
Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
inferred← citeshttps://doi.org/10.6084/m9.figshare.26629086openalex-snapshot
Additional file 1 of Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.